2TopicE, Simundic AM, Ttefanovic M, et al. Polymorphism of apoprotein E ( APOE ), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med, 2001,39:346-350.
3Mackness B, Durrington P, McElduff P, et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation ,2003,107:2775-2779.
4Kerkeni M, Addad F, Chauffert M, et aL Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Clin Biochem,2006,39:821-825.
5Roest M, Jansen AC, Barendrecht A, et al. Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia. Clin Biochem, 2005,38:123-127.
6Karvonen J, Kauma H, Paivansalo M, et al. Paraoxonase-1 gene Leu-Met55 and Gln-Arg192 polymorphisms are not associated with carotid artery atherosclerosis in a population-based cohort. Eur J Cardiovasc Prey Rehabil,2004,11:511-512.